Quince Therapeutics, Inc. (QNCX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Quince Therapeutics, Inc. on April 9, 2026. The filing reports the implementation of a previously approved reverse stock split and the associated amendment to the Company's Certificate of Incorporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and capital structure changes rather than financial performance.
Material Changes
- Reverse Stock Split: A 1-for-10 reverse stock split was approved by stockholders on June 4, 2025, and implemented via a Certificate of Amendment filed on April 9, 2026.
- Effective Date: The split becomes effective at 11:59 pm Eastern Time on April 10, 2026.
- Trading Resumption: Shares will begin trading on a split-adjusted basis on the Nasdaq Global Select Market on April 13, 2026.
- Share Count: Immediately following the split, approximately 16,300,795 shares of common stock will be issued and outstanding.
- Adjustments: All outstanding stock options and warrants have been proportionally adjusted. Fractional shares will be settled in cash.
- Identification: The stock will trade under the symbol "QNCX" with a new CUSIP number, 22053A206.
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, or specific risk factors beyond the standard disclosure that the discussion is qualified by the full text of the Certificate of Amendment. The primary operational impact is the administrative adjustment of share counts and the potential for cash payments in lieu of fractional shares.
Investor Verification Checklist
- Confirm the new CUSIP number (22053A206) is updated in brokerage accounts by April 13, 2026.
- Verify the adjusted number of shares held post-split (1/10th of pre-split holdings).
- Check for cash payments received in lieu of fractional shares if applicable.
- Review the adjusted strike prices and share quantities for any outstanding stock options or warrants.